Atrophy of superior cerebellar peduncle in progressive supranuclear palsy

Y. Tsuboi, J. Slowinski, K. A. Josephs, W. G. Honer, Z. K. Wszolek, D. W. Dickson

Research output: Contribution to journalArticlepeer-review

96 Scopus citations

Abstract

Background: Pathologic changes in the superior cerebellar peduncles (SCP) are common in progressive supranuclear palsy (PSP), but atrophy of the SCP has never been systematically studied. Objective: To investigate the SCP width in PSP cases and controls with morphometric methods. Methods: The mean width of the SCP in transverse sections of the pons at the level of trigeminal nerve was determined in 48 PSP cases (29 men, 19 women; mean age 72.5 ± 8.2 years) and 29 age-matched control subjects, many with neurodegenerative disorders that can be clinically mistaken for PSP. As the origin of the SCP is the cerebellar dentate nucleus, correlations were sought between SCP atrophy and severity of grumose degeneration in the dentate nucleus. Results: The average width of the SCP was less in PSP (range 0.09 to 0.24 cm) than in controls (range 0.21 to 0.43 cm; Mann-Whitney U test, p < 0.001), including control cases that had been clinically misdiagnosed as PSP (range 0.26 to 0.41 cm). Severity of SCP atrophy normalized by brain weight correlated with disease duration (Spearman rank order correlation, r = 0.367, p = 0.028), suggesting that SCP atrophy is a relatively early feature of PSP. No correlation was found between grumose degeneration and SCP width. Conclusions: SCP atrophy is common in PSP and correlates with disease duration. Given that measurements of the SCP are within the resolution of MRI, it remains to be determined if SCP atrophy can be used as a diagnostic marker of PSP.

Original languageEnglish (US)
Pages (from-to)1766-1769
Number of pages4
JournalNeurology
Volume60
Issue number11
DOIs
StatePublished - Jun 10 2003

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Atrophy of superior cerebellar peduncle in progressive supranuclear palsy'. Together they form a unique fingerprint.

Cite this